MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH Buys Shares of 16,294 Colgate-Palmolive (NYSE:CL)

MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH bought a new stake in Colgate-Palmolive (NYSE:CL) during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund bought 16,294 shares of the company’s stock, valued at approximately $1,467,000.

A number of other large investors have also modified their holdings of the business. Farmers & Merchants Investments Inc. grew its stake in shares of Colgate-Palmolive by 1.2% during the first quarter. Farmers & Merchants Investments Inc. now owns 36,381 shares of the company’s stock worth $3,276,000 after acquiring an additional 431 shares during the last quarter. Allspring Global Investments Holdings LLC grew its stake in shares of Colgate-Palmolive by 461.5% during the first quarter. Allspring Global Investments Holdings LLC now owns 1,036,215 shares of the company’s stock worth $93,311,000 after acquiring an additional 851,671 shares during the last quarter. Hexagon Capital Partners LLC grew its stake in shares of Colgate-Palmolive by 49.6% during the first quarter. Hexagon Capital Partners LLC now owns 1,164 shares of the company’s stock worth $105,000 after acquiring an additional 386 shares during the last quarter. Claro Advisors LLC grew its stake in shares of Colgate-Palmolive by 3.5% during the first quarter. Claro Advisors LLC now owns 20,334 shares of the company’s stock worth $1,831,000 after acquiring an additional 697 shares during the last quarter. Finally, Horizon Wealth Management LLC grew its stake in shares of Colgate-Palmolive by 3.2% during the first quarter. Horizon Wealth Management LLC now owns 4,525 shares of the company’s stock worth $407,000 after acquiring an additional 139 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Up 0.6 %

Colgate-Palmolive stock opened at $96.12 on Wednesday. The stock has a market capitalization of $78.86 billion, a PE ratio of 30.42, a price-to-earnings-growth ratio of 3.57 and a beta of 0.39. Colgate-Palmolive has a 12 month low of $67.62 and a 12 month high of $99.08. The business has a 50 day simple moving average of $94.02 and a 200-day simple moving average of $87.76. The company has a debt-to-equity ratio of 13.21, a current ratio of 1.06 and a quick ratio of 0.70.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, April 26th. The company reported $0.86 EPS for the quarter, beating analysts’ consensus estimates of $0.82 by $0.04. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. The business had revenue of $5.07 billion during the quarter, compared to analysts’ expectations of $4.96 billion. During the same period in the previous year, the business earned $0.73 earnings per share. The business’s revenue was up 6.2% compared to the same quarter last year. On average, analysts anticipate that Colgate-Palmolive will post 3.53 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, August 15th. Investors of record on Friday, July 19th will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.08%. The ex-dividend date is Friday, July 19th. Colgate-Palmolive’s payout ratio is 63.29%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the company. Morgan Stanley lifted their target price on Colgate-Palmolive from $101.00 to $103.00 and gave the stock an “overweight” rating in a report on Tuesday, May 28th. Citigroup lifted their target price on Colgate-Palmolive from $95.00 to $100.00 and gave the stock a “buy” rating in a report on Tuesday, April 16th. Wells Fargo & Company lifted their target price on Colgate-Palmolive from $90.00 to $92.00 and gave the stock an “equal weight” rating in a report on Monday, April 29th. Stifel Nicolaus lifted their target price on Colgate-Palmolive from $94.00 to $95.00 and gave the stock a “buy” rating in a report on Monday, April 29th. Finally, Argus lifted their target price on Colgate-Palmolive from $97.00 to $107.00 and gave the stock a “buy” rating in a report on Wednesday, May 15th. Three equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat, Colgate-Palmolive has an average rating of “Moderate Buy” and a consensus price target of $93.83.

Insider Buying and Selling

In related news, insider John W. Kooyman sold 3,497 shares of the business’s stock in a transaction that occurred on Tuesday, May 7th. The stock was sold at an average price of $93.47, for a total transaction of $326,864.59. Following the completion of the sale, the insider now directly owns 3,181 shares in the company, valued at $297,328.07. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, insider John W. Kooyman sold 3,497 shares of the business’s stock in a transaction that occurred on Tuesday, May 7th. The stock was sold at an average price of $93.47, for a total transaction of $326,864.59. Following the completion of the sale, the insider now directly owns 3,181 shares in the company, valued at $297,328.07. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Sally Massey sold 12,226 shares of the company’s stock in a transaction on Thursday, May 9th. The shares were sold at an average price of $94.06, for a total value of $1,149,977.56. Following the completion of the sale, the insider now owns 13,924 shares of the company’s stock, valued at $1,309,691.44. The disclosure for this sale can be found here. 0.37% of the stock is owned by company insiders.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.